Rejected at 4:28 p.m. Oct, 02, 2024 ] by mitchelnelson
Author: nine.seven
Related Note: 1509828770735 1
Rationale for change

Per AMBOSS, severe disease is treated with oral atovaquone PLUS IV azithromycin. Mild disease is treated with oral atovaquone PLUS oral azithromycin. Routes are included on the card because this is the difference in treatment between mild and severe disease.

Rejection reason

Suggestion no longer needed as other accepted suggestion has updated the card

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Empty field
Additional Resources
One by one
Empty field
#AK_Other::Only_Step_1 #AK_Step1_v12::#Bootcamp::Microbiology::21_Systemic_Protozoa::06_Babesia #AK_Step1_v12::#Low/HighYield::4-LowerYield #AK_Step1_v12::#FirstAid::03_Microbiology::04_Parasitology::03_Protozoa-hematologic_infections::*Babesia #AK_Step1_v12::#B&B::14_Infectious_Disease::05_Parasites_and_Helminths::02_Protozoa::Extra #AK_Other::AnKing_Image::!Subjects::Microbiology::Intraerythrocytic_protozoa #AK_Step1_v12::#OME::PreClinical::Microbiology::Microbiology_5::Parasites::Protozoa #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Physeo::09_Pharm::05_Antibiotics::16_Macrolides #AK_Step1_v12::#Bootcamp::Microbiology::38_Antiparasitics::04_Chloroquine-Resistant_and_Exo-Erythrocytic_Antimalarials #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::02_Inhibitors_of_Bacterial_Protein_Synthesis::02_Macrolides #PANCE::INFECTIOUS_DISEASE::parasitic_diseases #AK_Step1_v12::#SketchyMicro::04_Parasites::03_Protozoa_of_the_Blood::02_Babesia_spp. #AK_Step1_v12::#Physeo::06_Micro::04_Parasites::08_Babesia_&_Anaplasma #AK_Other::AnKing_Image::MS::Intraerythrocytic_protozoa #AK_Other::#AK_Original_Decks::Step_1::Lolnotacop::Bugs